Search filters

List of works by Roland B Walter

A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia

scientific article published on 6 July 2013

A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia

scientific article published in December 2017

A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia

scientific article published on 16 April 2013

A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age.

scientific article

AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab ozogamicin

scientific article

Acidosis induced by lactate, pyruvate, or HCl increases blood viscosity

scientific article published in March 2002

Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies

scientific article published on 18 March 2016

Acute myeloid leukemia stem cells and CD33-targeted immunotherapy ⬇️

scientific article published on January 27, 2012

Acute, life-threatening hypoglycemia associated with haloperidol in a hematopoietic stem cell transplant recipient

scientific article

Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study

scientific article published on 19 April 2019

Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin

scientific article published on June 2013

Assessment of digital clubbing in medical inpatients by digital photography and computerized analysis.

scientific article published on March 2002

Association between plasma thiols and immune activation marker neopterin in stable coronary heart disease

scientific article published in January 2008

Associations between allergies and risk of hematologic malignancies: results from the VITamins and lifestyle cohort study

scientific article published on December 2013

Biting back: BiTE antibodies as a promising therapy for acute myeloid leukemia

scientific article published on 11 March 2014

Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-gamma1 in acute myeloid leukemia cells.

scientific article

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

scientific article published on 06 June 2013

COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia

scientific article published on 11 September 2018

Cancer risk associated with long-term use of acetaminophen in the prospective VITamins and lifestyle (VITAL) study

scientific article published on 12 October 2011

Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML.

scientific article published on 05 December 2013

Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML)

scientific article published on 03 December 2020

Chronic myeloid leukemia in lymphoid blast crisis

scientific article published on 7 March 2014

Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin–Containing Chemotherapy ⬇️

scientific article published on February 26, 2013

Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid

scientific article published on 26 May 2015

Comparative analysis of total body irradiation (TBI)-based and non-TBI-based myeloablative conditioning for acute myeloid leukemia in remission with or without measurable residual disease

scientific article published on 03 December 2019

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

scientific article published on 19 August 2020

Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study

scientific article published on 4 April 2003

Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with acute myeloid leukemia

scientific article published on 19 December 2014

Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML ⬇️

scientific article published on February 29, 2012

Critical role of interleukin-1beta for transcriptional regulation of endothelial 6-pyruvoyltetrahydropterin synthase

scientific article published on 9 October 2003

Cyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study ⬇️

scientific article published on March 27, 2013

Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AML.

scientific article published on 20 April 2018

Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans

scientific article

Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia

scientific article published on 04 November 2019

Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm

scientific article published on 04 October 2019

Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia

scientific article published on 20 March 2015

Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study

scientific article

Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia

scientific article

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG.

scientific article published on 9 July 2015

Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR/Cas9-deletion of CD33 exon 2

scientific article published on 05 October 2018

Expression of the hemoglobin scavenger receptor (CD163/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia

scientific article published on 01 May 2003

Factors associated with early reinduction chemotherapy for adults with acute myeloid leukemia

scientific article published on 17 July 2014

Fatal hepatic veno-occlusive disease associated with terbinafine in a liver transplant recipient.

scientific article published in March 2003

Fatal necrotizing fasciitis due to Streptococcus pneumoniae after renal transplantation

scientific article published in January 2003

Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy

scientific article

Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission

scientific article published on 23 September 2013

Functional expression of the CD163 scavenger receptor on acute myeloid leukemia cells of monocytic lineage.

scientific article published on 20 December 2005

Gemcitabine-associated hemolytic-uremic syndrome

scientific article

Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study

scientific article

Height as an explanatory factor for sex differences in human cancer

scientific article published on 24 May 2013

High expression of neutrophil elastase predicts improved survival in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

scientific article published on 09 July 2012

High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

scientific article

High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group

scientific article

How Do Pretransplantation Peripheral Blood Counts Inform Us about Post-Transplantation Outcomes in Acute Myeloid Leukemia?

scientific article published on 20 May 2015

ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2

scientific article

Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome. ⬇️

scientific article published on 27 February 2015

Images in clinical medicine. Vitiligo and pernicious anemia

scientific article

Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML

scientific article published on 23 January 2020

Impairment of blood rheology by cholestatic jaundice in human beings

scientific article

Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity

scientific article published on 28 September 2004

Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.

scientific article

Letter regarding article by Vita et al, "serum myeloperoxidase levels independently predict endothelial dysfunction in humans"

scientific article published on 01 March 2005

Long-Term Use of Acetaminophen, Aspirin, and Other Nonsteroidal Anti-Inflammatory Drugs and Risk of Hematologic Malignancies: Results From the Prospective Vitamins and Lifestyle (VITAL) Study ⬇️

scientific article published on May 9, 2011

Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy

scientific article published on 4 February 2015

Mcl-1 dependence predicts response to vorinostat and gemtuzumab ozogamicin in acute myeloid leukemia.

scientific article

Mechanism of Endocytosis of CD33/SIGLEC-3: Role of ITIMs, Tyrosine Phosphorylation, and Monoubiquitylation ⬇️

doctoral thesis by Roland Bruno Walter, 2006

Metastatic squamous cell carcinoma with marked blood eosinophilia and elevated serum interleukin-5 levels

scientific article published on 01 January 2002

Minimal residual disease in acute myeloid leukemia--current status and future perspectives

scientific article published on June 2015

Minimal residual disease-directed therapy in acute myeloid leukemia

scientific article

Minimal/measurable residual disease in AML: consensus document from ELN MRD Working Party.

scientific article published on 12 January 2018

Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study

scientific article published on 30 May 2017

Mott cells

scientific article published on 26 October 2012

Multidrug resistance protein attenuates gemtuzumab ozogamicin-induced cytotoxicity in acute myeloid leukemia cells.

scientific article

Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

scientific article published on 30 March 2015

Myeloid sarcoma of the heart.

scientific article

Need for routine examination of left ventricular ejection fraction in patients with AML

scientific article published on 12 November 2019

Next-generation sequencing for measuring minimal residual disease in AML

scientific article published on 01 August 2018

Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative

scientific article published on 20 March 2014

Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission

scientific article

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

scientific article published on 20 March 2014

Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design

scientific article

Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot study ⬇️

scientific article published on March 10, 2011

Outpatient management following intensive induction or salvage chemotherapy for acute myeloid leukemia

scientific article

Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms

scientific article published on 17 April 2018

Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia ⬇️

scientific article published on December 1, 2011

Phosphorylated ITIMs enable ubiquitylation of an inhibitory cell surface receptor

scientific article published on 18 December 2007

Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remission

scientific article published on 25 February 2019

Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia

scientific article published on 28 February 2014

Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment

scientific article published on 3 October 2011

Pretargeted radioimmunotherapy for hematologic and other malignancies

scientific article

Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.

scientific article

Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia ⬇️

scientific article published on July 23, 2012

Quality of life from the perspective of the patient with acute myeloid leukemia

scientific article published on 7 September 2017

Rapid detection of pathogenic fungi from clinical specimens using LightCycler real-time fluorescence PCR.

scientific article published on 21 August 2003

Rapid rate of peripheral blood blast clearance accurately predicts complete remission in acute myeloid leukemia

scientific article published on 18 November 2013

Refining AML outcome prediction

scientific article published on 14 December 2018

Regular recreational physical activity and risk of hematologic malignancies: results from the prospective VITamins And lifestyle (VITAL) study ⬇️

scientific article published on December 17, 2012

Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia

scientific article published on 2 March 2015

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center.

scientific article

SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML.

scientific article published on 14 June 2013

Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusion

scientific article

Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials

scientific article published on 12 October 2018

Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients

scientific article published on 16 January 2013

Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission

scientific article published on 11 July 2013

Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation

scientific article published on 31 January 2018

Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia

scientific article published on 2 February 2017

Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantation

scientific article published on 30 October 2019

Targeted drug delivery by gemtuzumab ozogamicin: mechanism-based mathematical model for treatment strategy improvement and therapy individualization

scientific article

Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapy

scientific article published in 2021

The Bruton's tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody-mediated T-cell cytotoxicity

scientific article published on 04 February 2020

The past and future of CD33 as therapeutic target in acute myeloid leukemia.

scientific article published on 21 April 2014

The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin

scientific article published on 12 February 2004

The power of comparative studies

scientific article published on 05 November 2008

The role of CD33 as therapeutic target in acute myeloid leukemia

scientific article

The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy

scientific article published on 30 January 2015

Update on antigen-specific immunotherapy of acute myeloid leukemia

scientific article published on June 2015

Value of routine 'day 14' marrow exam in newly diagnosed AML

scientific article published on 10 September 2014

Vitamin, Mineral, and Specialty Supplements and Risk of Hematologic Malignancies in the Prospective VITamins And Lifestyle (VITAL) Study ⬇️

scientific article published on July 29, 2011

Paulina is supported by:

About Paulina

Help